Turenne Capital Partenaires
Overview
Turenne Capital Partenaires, operating as Turenne Groupe, is an independent private equity firm that finances startups, SMEs, and mid-market companies at every stage of their development across France.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| SamanTree Medical | Jul 2024 | Series B | Lead |
| Pixee Medical | Feb 2024 | Series B | Lead |
| AlgoTx | Mar 2023 | Series B | Lead |
| Nexway | - | Seed | Co-investor |
| Cintoo | Dec 2017 | Seed | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Turenne Capital Partenaires based?
Turenne Capital Partenaires is headquartered in Paris, France.
When was Turenne Capital Partenaires founded?
Turenne Capital Partenaires was founded in 1999.
How many portfolio companies does Turenne Capital Partenaires have?
Turenne Capital Partenaires has 6 portfolio companies in Caplight's dataset.
What are some companies in Turenne Capital Partenaires's portfolio?
Portfolio companies visible on Caplight include SamanTree Medical, Pixee Medical, AlgoTx, Nexway, Cintoo.
What was Turenne Capital Partenaires's most recent investment shown here?
Turenne Capital Partenaires's most recent investment in this portfolio sample was in SamanTree Medical in 2024.
What sectors does Turenne Capital Partenaires focus on?
Turenne Capital Partenaires focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, FinTech, Enterprise Software, Frontier & Industrial Tech, Consumer & Commerce, Frontier & Industrial Tech.
What company stages does Turenne Capital Partenaires focus on?
Turenne Capital Partenaires typically invests at the Early stage.
What is Turenne Capital Partenaires's AUM?
Turenne Capital Partenaires's assets under management are estimated between $2.4B and $2.4B.